17 Dec 2018 --- Eisai has granted Brazilian pharmaceutical company Eurofarma the exclusive marketing and development rights for lorcaserin, an anti-obesity agent, in Brazil. Eisai reports the move will provide the means to leverage Eurofarma’s strong business foundation throughout Latin America to accelerate the delivery of lorcaserin to more patients.
